INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🔴 Indaptus Therapeutics is trading 6.1% down today as it retreats from a recent rebound
Indaptus Therapeutics is trading at $2.47 (6.1% down), retreating from its recent rebound after experiencing sharp volatility in prior sessions. • There are...
🟢 Indaptus Therapeutics is trading 5.6% up today amid speculative trading
Indaptus Therapeutics is trading 5.6% up today at $2.64 amid speculative trading and market volatility, as no specific company catalysts or regulatory...
🔴 INDP extends move to 8.4% down
INDP is trading at $2.44, down 8.4% versus the comparison close of $2.67 during regular trading. This is a price-movement alert; no separate company-specific...
Indaptus Therapeutics Is Burning Cash, Selling Shares at a Steep Discount, and Asking Investors to Trust the Plan — Should They?
Shares of Indaptus Therapeutics (INDP) slid 7.9% to $2.46 on July 8, extending a brutal 28% decline from $3.41 on June 26. The selloff reflects a convergence...
🔴 INDP is trading 7.9% down today on dilution fears and financing uncertainty
INDP is trading 7.9% down today at $2.46 as concerns mount over the company's immediate cash needs and the potential for dilutive financing. • The stock...
🔴 INDP is trading 6.4% down today, extending a multi-day slide amid financing uncertainty
INDP is trading at $2.50 (6.4% down) in pre-market, extending a multi-day slide from $3.41 on June 26 to $2.67 on July 7. • The stock continues to face heavy...
🔴 INDP is trading 6% down today amid continued volatility and financing uncertainty
INDP is trading approximately 6% down today at $2.68 following a sharp drop in the previous session and ongoing market uncertainty. • No new company filings,...
🔴 INDP is trading 8.4% down today with no clear catalyst
INDP is trading 8.4% down at $2.61 with no clear company-specific catalyst emerging so far. • This pre-market weakness appears idiosyncratic, as there are no...
Indaptus Sells Shares at 81% Below Market to Stay Alive — Can $12 Million Buy Enough Time for a Clinical-Stage Biotech With No Revenue?
Shares of Indaptus Therapeutics shifted sharply this week as the clinical-stage cancer immunotherapy company announced a $12 million Regulation S private...
🟢 INDP is trading 8.5% up today after rebounding from discounted $12M placement
INDP is trading at 8.5% up now at $3.19, rebounding after a sharply discounted $12 million Regulation S private placement announced on July 1, 2026. The...
🔴 INDP is trading 6.7% down today after $12M private placement at deep discount
INDP is trading 6.7% down at $2.80 in pre-market action after announcing a $12 million Regulation S private placement. • The company plans to issue 20 million...
🟢 INDP is trading 6% up today after $12M private placement
Indaptus Therapeutics (INDP) is trading at $3.18 (6% up) in pre-market. The positive movement follows the company's recent announcement of a $12 million...
🔴 INDP makes sharp 14.1% drop
INDP is trading at $2.93, down 14.1% versus the comparison close of $3.41 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 INDP is trading 5.6% down today after trial enrollment halt and share resale filing
INDP is trading 5.6% down at $3.22 as the market reacts to Indaptus Therapeutics halting a clinical trial and filing for a significant share resale. • The...
Indaptus Halts Cancer Trial Enrollment, Files to Resell 18.8M Shares
Indaptus Therapeutics filed an SEC registration statement for the resale of 18.864 million common shares. This follows a private placement that raised...
🟢 INDP makes sharp 10.4% jump
INDP is trading at $3.60, up 10.4% versus the comparison close of $3.26 during regular trading. This is a price-movement alert; no separate company-specific...
Indaptus Therapeutics Finds a Floor After $12M Placement Rout — But Can a Cash-Starved Biotech Survive Its Own Dilution Cycle?
Shares of Indaptus Therapeutics (INDP) edged up 3.4% to $3.37 on June 26, the first green day after a punishing selloff that shaved roughly 14% off the stock...
🟢 INDP is trading 3.4% up today as it stabilizes following $12M private placement selloff
INDP is trading at $3.37 (3.4%) up today as the stock appears to be stabilizing and modestly rebounding following several days of pressure tied to its recent...
🔴 INDP is trading 6.2% down today following $12M private placement news
INDP is trading 6.2% down at $3.33 following a sharp multi-day pullback and news of a $12 million private placement. • The company entered into a $12 million...
Indaptus Therapeutics Announces $12 Million Private Placement of Common Stock
Indaptus Therapeutics, Inc. has entered into a Stock Purchase Agreement with certain non-U.S. accredited investors for a private placement of its common stock....